World's Best Scientists 2026 revealed!
Haruo Sugiyama

Haruo Sugiyama

D-Index & Metrics

Microbiology

D-Index
71
Citations
18302
World Ranking
1844
National Ranking
56

Haruo Sugiyama publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Haruo Sugiyama sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 265 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 234 scientists 205–214 publications: 208 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 370 publications — 87th percentile

87% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Haruo Sugiyama D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Haruo Sugiyama sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 112 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 123 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 94 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 71 D-Index — 67th percentile

67% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Haruo Sugiyama is affiliated with Osaka University in Japan and has contributed extensively to research in medicine, immunology, and molecular biology. Their scientific work spans multiple subfields, with a focus on oncology, immunology, and molecular biology, along with areas including pulmonary and respiratory medicine, and radiology, nuclear medicine, and imaging.

Their main research topics include immunotherapy and immune responses, renal and related cancers, CAR-T cell therapy research, cancer immunotherapy and biomarkers, pancreatic and hepatic oncology research, immune cell function and interaction, as well as epigenetics and DNA methylation.

Sugiyama has authored several papers published in notable scientific journals. Some of their recent papers include:

  • Prognostic value of immune factors in the tumor microenvironment of patients with pancreatic ductal adenocarcinoma, 2021, BMC Cancer
  • Dendritic Cell-based Immunotherapy Pulsed With Wilms Tumor 1 Peptide and Mucin 1 as an Adjuvant Therapy for Pancreatic Ductal Adenocarcinoma After Curative Resection: A Phase I/IIa Clinical Trial, 2020, Anticancer Research
  • Selective targeting of multiple myeloma cells with a monoclonal antibody recognizing the ubiquitous protein CD98 heavy chain, 2022, Science Translational Medicine
  • Cellular and Humoral Immune Responses Induced by an HLA Class I-restricted Peptide Cancer Vaccine Targeting WT1 Are Associated With Favorable Clinical Outcomes in Advanced Ovarian Cancer, 2021, Journal of Immunotherapy
  • Regeneration of Tumor-Antigen-Specific Cytotoxic T Lymphocytes from iPSCs Transduced with Exogenous TCR Genes, 2020, Molecular Therapy - Methods & Clinical Development

The frequent co-authors collaborating with Sugiyama include Yoshitaka Oka, Yusuke Oji, Akihiro Tsuboi, Soyoko Morimoto, and Fumihiro Fujiki. These collaborations reflect a network of researchers contributing to related fields.

The scientist's work is frequently published in journals such as Cancer Immunology Immunotherapy, Circulation, Journal for ImmunoTherapy of Cancer, Journal of Hematology & Oncology, and Cancers. The range of venues demonstrates a multidisciplinary approach within biomedical research.

Best Publications

  • Induction of WT1 (Wilms' tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression

    Yoshihiro Oka;Akihiro Tsuboi;Tetsuya Taguchi;Tadashi Osaki

  • WT1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia.

    K Inoue;H Sugiyama;H Ogawa;M Nakagawa

  • CD96 is a leukemic stem cell-specific marker in human acute myeloid leukemia

    Naoki Hosen;Christopher Y. Park;Naoya Tatsumi;Yusuke Oji

  • Aberrant Overexpression of the Wilms Tumor Gene (WT1) in Human Leukemia

    Kazushi Inoue;Hiroyasu Ogawa;Hiroyasu Ogawa;Yoshiaki Sonoda;Yoshiaki Sonoda;Takafumi Kimura;Takafumi Kimura

  • Induction of complete and molecular remissions in acute myeloid leukemia by Wilms’ tumor 1 antigen-targeted dendritic cell vaccination

    Viggo F. van Tendeloo;Ann Van de Velde;Ann van Driessche;Nathalie Cools

  • Human cytotoxic T-lymphocyte responses specific for peptides of the wild-type Wilms' tumor gene (WT1 ) product.

    Yoshihiro Oka;Olga A. Elisseeva;Akihiro Tsuboi;Hiroyasu Ogawa

  • Immunohistochemical detection of WT1 protein in a variety of cancer cells

    Shin-ichi Nakatsuka;Yusuke Oji;Tetsuya Horiuchi;Takayoshi Kanda

  • Growth inhibition of human leukemic cells by WT1 (Wilms tumor gene) antisense oligodeoxynucleotides: implications for the involvement of WT1 in leukemogenesis

    T Yamagami;H Sugiyama;K Inoue;H Ogawa

  • Cancer Immunotherapy Targeting Wilms’ Tumor Gene WT1 Product

    Yoshihiro Oka;Keiko Udaka;Akihiro Tsuboi;Olga A. Elisseeva

  • The usefulness of monitoring WT1 gene transcripts for the prediction and management of relapse following allogeneic stem cell transplantation in acute type leukemia.

    Hiroyasu Ogawa;Hiroya Tamaki;Kazuhiro Ikegame;Toshihiro Soma

  • Expression of the Wilms' tumor gene WT1 in solid tumors and its involvement in tumor cell growth.

    Yusuke Oji;Hiroyasu Ogawa;Hiroya Tamaki;Yoshihiro Oka

  • Overexpression of the Wilms' tumor gene WT1 in de novo lung cancers

    Yusuke Oji;Shinichiro Miyoshi;Hajime Maeda;Seiji Hayashi

  • Phase II clinical trial of Wilms tumor 1 peptide vaccination for patients with recurrent glioblastoma multiforme.

    Shuichi Izumoto;Akihiro Tsuboi;Yoshihiro Oka;Tsuyoshi Suzuki

  • High expression of Wilms' tumor suppressor gene predicts poor prognosis in breast cancer patients.

    Yasuo Miyoshi;Akiko Ando;Chiyomi Egawa;Tetsuya Taguchi

  • WT1 (Wilms' tumor gene 1): biology and cancer immunotherapy

    Haruo Sugiyama

  • Long-term follow-up of minimal residual disease in leukemia patients by monitoring WT1 (Wilms tumor gene) expression levels

    Kazushi Inoue;Hiroyasu Ogawa;Tamotsu Yamagami;Toshihiro Soma

  • Wilms' tumor gene (WT1) competes with differentiation-inducing signal in hematopoietic progenitor cells

    Kazushi Inoue;Hiroya Tamaki;Hiroyasu Ogawa;Yoshihiro Oka

  • The Wilms' tumor gene WT1 is a good marker for diagnosis of disease progression of myelodysplastic syndromes.

    H. Tamaki;H. Ogawa;K. Ohyashiki;Jh H. Ohyashiki

  • Dendritic cell vaccination as postremission treatment to prevent or delay relapse in acute myeloid leukemia

    Sébastien Anguille;Ann L. Van De Velde;Evelien L. Smits;Viggo F. Van Tendeloo

  • Characterization of Y73, an avian sarcoma virus: a unique transforming gene and its product, a phosphopolyprotein with protein kinase activity.

    Sadaaki Kawai;Mitsuaki Yoshida;Kaoru Segawa;Haruo Sugiyama

Frequent Co-Authors

Yoshihiro Oka
Yoshihiro Oka Osaka University
Yusuke Oji
Yusuke Oji Osaka University
Katsuyuki Aozasa
Katsuyuki Aozasa Osaka University
Tadamitsu Kishimoto
Tadamitsu Kishimoto Osaka University
Atsushi Kumanogoh
Atsushi Kumanogoh Osaka University
Satoshi Morita
Satoshi Morita Kyoto University
Yuzuru Kanakura
Yuzuru Kanakura Osaka University
Eiichi Morii
Eiichi Morii Osaka University
Toshihisa Komori
Toshihisa Komori Nagasaki University
Masaki Yasukawa
Masaki Yasukawa Ehime University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring microbiology in the USA opens doors to various related online degrees that can enhance your career opportunities. For individuals facing unique challenges, such as a criminal record, there are tailored programs that offer flexibility and second chances. Check out degrees for felons to find accessible pathways that accommodate different backgrounds.

Healthcare professions that complement microbiology studies include becoming a functional medicine nurse practitioner. This role blends clinical skills with a holistic approach to patient care, and pursuing this path can lead to a rewarding functional medicine nurse salary.

Additionally, fields like medical coding and health data management are vital to healthcare systems. Obtaining credentials like CPC certification presents career stability and growth, as highlighted in the cpc salary and career paths overview.

For those interested in the administrative side of healthcare, health information management offers a promising route. Learning about health information management salary and career pathways provides insight into this critical sector, which supports healthcare delivery through data accuracy and security.

Best Scientists Citing Haruo Sugiyama

Trending Scientists